Human Polymorphonuclear Neutrophil Responses to Burkholderia pseudomallei in Healthy and Diabetic Subjects

被引:102
作者
Chanchamroen, Sujin [1 ]
Kewcharoenwong, Chidchamai [1 ]
Susaengrat, Wattanachai [2 ]
Ato, Manabu [3 ]
Lertmemongkolchai, Ganjana [1 ]
机构
[1] Khon Kaen Univ, Fac Associated Med Sci, Ctr Res & Dev Med Diagnost Labs, Khon Kaen, Thailand
[2] Khon Kaen Hosp, Dept Med, Minist Publ Hlth, Khon Kaen, Thailand
[3] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan
关键词
COLONY-STIMULATING FACTOR; WHOLE-BLOOD; YERSINIA-ENTEROCOLITICA; PSEUDOMONAS-PSEUDOMALLEI; SPONTANEOUS APOPTOSIS; BACTERIAL PATHOGENS; FLOW-CYTOMETRY; RISK-FACTORS; HOST-CELLS; MELIOIDOSIS;
D O I
10.1128/IAI.00503-08
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The major predisposing factor for melioidosis is diabetes mellitus, but no immunological mechanisms have been investigated to explain this. In this study, polymorphonuclear neutrophil (PMN) responses to Burkholderia pseudomallei, the causative agent of melioidosis, in healthy and diabetic Thai subjects were determined by flow cytometry. The results showed that B. pseudomallei displayed reduced uptake by PMNs compared to Salmonella enterica serovar Typhimurium and Escherichia coli. Additionally, intracellular survival of B. pseudomallei was detected throughout a 24-h period, indicating the intrinsic resistance of B. pseudomallei to killing by PMNs. Moreover, PMNs from diabetic subjects displayed impaired phagocytosis of B. pseudomallei, reduced migration in response to interleukin-8, and an inability to delay apoptosis. These data show that B. pseudomallei is intrinsically resistant to phagocytosis and killing by PMNs. These observations, together with the impaired migration and apoptosis in diabetes mellitus, may explain host susceptibility in melioidosis.
引用
收藏
页码:456 / 463
页数:8
相关论文
共 45 条
  • [11] Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes
    Egan, AM
    Gordon, DL
    [J]. INFECTION AND IMMUNITY, 1996, 64 (12) : 4952 - 4959
  • [12] Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x
  • [13] INVIVO CREVICULAR LEUKOCYTE RESPONSE TO A CHEMOTACTIC CHALLENGE - INHIBITION BY EXPERIMENTAL DIABETES
    GOLUB, LM
    NICOLL, GA
    IACONO, VJ
    RAMAMURTHY, NS
    [J]. INFECTION AND IMMUNITY, 1982, 37 (03) : 1013 - 1020
  • [14] Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis
    Grosdent, N
    Maridonneau-Parini, I
    Sory, MP
    Cornelis, GR
    [J]. INFECTION AND IMMUNITY, 2002, 70 (08) : 4165 - 4176
  • [15] YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells
    Iriarte, M
    Cornelis, GR
    [J]. MOLECULAR MICROBIOLOGY, 1998, 29 (03) : 915 - 929
  • [16] Intracellular survival of Burkholderia pseudomallei
    Jones, AL
    Beveridge, TJ
    Woods, DE
    [J]. INFECTION AND IMMUNITY, 1996, 64 (03) : 782 - 790
  • [17] Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils
    Kobayashi, SD
    Braughton, KR
    Whitney, AR
    Voyich, JM
    Schwan, TG
    Musser, JM
    DeLeo, FR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10948 - 10953
  • [18] Recent development in melioidosis
    Leelarasamee, A
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (02) : 131 - 136
  • [19] Risk factors for recurrent melioidosis in northeast Thailand
    Limmathurotsakul, Direk
    Chaowagul, Wipada
    Chierakul, Wirongrong
    Stepniewska, Kasia
    Maharjan, Bina
    Wuthiekanun, Vanaporn
    White, Nicholas J.
    Day, Nicholas P. J.
    Peacock, Sharon J.
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (08) : 979 - 986
  • [20] Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control
    Lin, Jung-Chung
    Siu, L. K.
    Fung, Chang-Phone
    Tsou, Hsiao-Hui
    Wang, Jaang-Jiun
    Chen, Chiung-Tong
    Wang, Shu-Chuan
    Chang, Feng-Yee
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) : 3084 - 3087